Where Will RocketLab Stock Be In 5 Years?
Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…
Buy
64
THYKF Quote, Financials, Valuation and Earnings
Last price:
$10.76
Seasonality move
:
-17.03%
Day range:
$10.76 - $10.76
52-week range:
$8.53 - $11.80
Dividend yield:
0%
P/E ratio:
58.19x
P/S ratio:
1.31x
P/B ratio:
1.65x
Volume:
700
Avg. volume:
30
1-year change:
1.3%
Market cap:
$1.4B
Revenue:
$935.1M
EPS (TTM):
$0.18
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, thyssenkrupp nucera AG & has -- downside to fair value with a price target of -- per share.
THYKF vs. S&P 500
-
Over the past 5 trading days, thyssenkrupp nucera AG & has overperformed the S&P 500 by 8.84% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
thyssenkrupp nucera AG & does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
thyssenkrupp nucera AG & has grown year-over-year revenues for 0 quarters straight. In the most recent quarter thyssenkrupp nucera AG & reported revenues of $227.3M.
Earnings Growth
-
thyssenkrupp nucera AG & has grown year-over-year earnings for 0 quarters straight. In the most recent quarter thyssenkrupp nucera AG & reported earnings per share of -$0.03.
Enterprise value:
597M
EV / Invested capital:
0.73x
Price / LTM sales:
1.31x
EV / EBIT:
20.81x
EV / Revenue:
0.58x
PEG ratio (5yr expected):
0.15x
EV / Free cash flow:
-12.03x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
15.93x
Gross Profit (TTM):
$110.2M
Return On Assets:
1.72%
Net Income Margin (TTM):
2.25%
Return On Equity:
2.87%
Return On Invested Capital:
2.87%
Operating Margin:
-3.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $536.9M | $788M | $1B | $179.2M | $227.3M | |
| Gross Profit | -- | $91.2M | $110.2M | $14.1M | $21M | |
| Operating Income | -- | -$9.3M | -$8.5M | -$17.4M | -$7.4M | |
| EBITDA | -- | $23.9M | $37.5M | -$5.4M | $4.2M | |
| Diluted EPS | -- | $0.04 | $0.18 | -$0.09 | -$0.03 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $537.8M | $1.2B | $1.3B | |
| Total Assets | -- | -- | $625.4M | $1.3B | $1.4B | |
| Current Liabilities | -- | -- | $363.1M | $458.7M | $542.2M | |
| Total Liabilities | -- | -- | $385.9M | $487.3M | $591M | |
| Total Equity | -- | -- | $239.5M | $793.1M | $822.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $79.8M | -- | -$25M | -$15.1M | $572.1K | |
| Cash From Investing | -- | -- | -$23.5M | -$3.3M | -$6.2M | |
| Cash From Financing | -- | -- | -$4.3M | -$1.1M | -$1M | |
| Free Cash Flow | -- | -- | -$49.6M | -$15.1M | -$4.6M | |
THYKF
Sector
Market Cap
$1.4B
$611.3M
Price % of 52-Week High
91.17%
78.02%
Dividend Yield
0%
0%
Shareholder Yield
--
2.29%
1-Year Price Total Return
1.3%
-1.49%
Beta (5-Year)
--
0.777
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$10.26
200-day SMA
Buy
Level
$9.68
Bollinger Bands (100)
Buy
Level
8.99 - 10.41
Chaikin Money Flow
Sell
Level
-1.7K
20-day SMA
Buy
Level
$10.04
Relative Strength Index (RSI14)
Buy
Level
81.63
ADX Line
Buy
Level
28.78
Williams %R
Sell
Level
-15.4483
50-day SMA
Buy
Level
$9.79
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Sell
Level
-12.9K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7463)
Buy
CA Score
(Annual)
Level (0.4186)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.2814)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
thyssenkrupp nucera AG & Co is a provider of technologies for high-efficiency electrolysis plants. Its green hydrogen technology enables customers to minimize their carbon footprint and transform their operations into net zero. The company is a technology leader in the chlor-alkali sector. Its experience in the chlor-alkali business stretches over five decades, providing a basis for the development and upscaling of its alkaline water electrolysis (AWE) business. AWE is an industrial-scale green hydrogen production technology for the company. It enables customers to produce large volumes of hydrogen with a standardized modular approach at the cost of ownership. The company has five geographical segments; Germany, Italy, Japan, China and Rest of the world.
Stock Forecast FAQ
In the current month, THYKF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The THYKF average analyst price target in the past 3 months is --.
-
Where Will thyssenkrupp nucera AG & Stock Be In 1 Year?
According to analysts, the consensus estimate is that thyssenkrupp nucera AG & share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About thyssenkrupp nucera AG &?
Analysts are divided on their view about thyssenkrupp nucera AG & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that thyssenkrupp nucera AG & is a Sell and believe this share price will rise from its current level to --.
-
What Is thyssenkrupp nucera AG &'s Price Target?
The price target for thyssenkrupp nucera AG & over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is THYKF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for thyssenkrupp nucera AG & is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of THYKF?
You can purchase shares of thyssenkrupp nucera AG & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase thyssenkrupp nucera AG & shares.
-
What Is The thyssenkrupp nucera AG & Share Price Today?
thyssenkrupp nucera AG & was last trading at $10.76 per share. This represents the most recent stock quote for thyssenkrupp nucera AG &. Yesterday, thyssenkrupp nucera AG & closed at $10.76 per share.
-
How To Buy thyssenkrupp nucera AG & Stock Online?
In order to purchase thyssenkrupp nucera AG & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is MO dividend Worth It?
Altria Group (NYSE: MO) is paying investors $1.02 a share…
How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
